Form 424B5 Phio Pharmaceuticals Corp For: 8 April
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phio Pharmaceuticals Corp (PHIO)
Phio Pharmaceuticals Corp stock price live, this page displays NASDAQ PHIO stock exchange data. View the PHIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Phio Pharmaceuticals Corp real time stock price chart below.
What Is the Phio Pharmaceuticals Corp Stock Price Today?
The Phio Pharmaceuticals Corp stock price today is 1.220.
What Is the Stock Symbol for Phio Pharmaceuticals Corp?
The stock symbol for Phio Pharmaceuticals Corp is "PHIO."
What Stock Exchange Does Phio Pharmaceuticals Corp Trade On?
Phio Pharmaceuticals Corp is listed and trades on the NASDAQ stock exchange.
Is Phio Pharmaceuticals Corp a Good Stock to Buy?
Determining whether Phio Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHIO quote. (ISIN: US71880W5013)
What Is the Phio Pharmaceuticals Corp Stock Price Today?
The Phio Pharmaceuticals Corp stock price today is 1.220.
What Is the Stock Symbol for Phio Pharmaceuticals Corp?
The stock symbol for Phio Pharmaceuticals Corp is "PHIO."
What Stock Exchange Does Phio Pharmaceuticals Corp Trade On?
Phio Pharmaceuticals Corp is listed and trades on the NASDAQ stock exchange.
Is Phio Pharmaceuticals Corp a Good Stock to Buy?
Determining whether Phio Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHIO quote. (ISIN: US71880W5013)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.191
1.230
52 wk Range
0.813
4.190
PHIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1911.230
52 wk Range
0.8134.190
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHIO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
14.000
Upside
+1,047.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Phio Pharmaceuticals Corp For: 8 April
- Investing.com
- Form 8K Phio Pharmaceuticals Corp For: 30 March
- Investing.com
- Form 424B5 Phio Pharmaceuticals Corp For: 8 April
- Investing.com
- Form 8K Phio Pharmaceuticals Corp For: 8 April
- Investing.com
- Form 8K Phio Pharmaceuticals Corp For: 30 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.000
(+1,047.54% Upside)
Earnings
Latest Release
Mar 05, 2026
EPS / Forecast
-0.25 / -0.41
Revenue / Forecast
-- / --
Compare PHIO to Peers and Sector
Metrics to compare | PHIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | −3.2x | −0.5x | |
PEG Ratio | −0.02 | −0.04 | 0.00 | |
Price/Book | 0.7x | 4.6x | 2.6x | |
Price / LTM Sales | - | 127.3x | 3.2x | |
Upside (Analyst Target) | - | 258.3% | 48.8% | |
Fair Value Upside | Unlock | −0.5% | 6.9% | Unlock |
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Phio Pharma (PHIO) Stock Price Today?
The Phio Pharma stock price today is 1.220 USD.
What Stock Exchange Does Phio Pharma Trade On?
Phio Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Phio Pharma?
The stock symbol for Phio Pharma is "PHIO."
What Is the Phio Pharma Market Cap?
As of today, Phio Pharma market cap is 14.230M USD.
What Is Phio Pharma's Earnings Per Share (TTM)?
The Phio Pharma EPS (TTM) is -1.454.
From a Technical Analysis Perspective, Is PHIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Phio Pharma Stock Split?
Phio Pharma has split 6 times.
How Many Employees Does Phio Pharma Have?
Phio Pharma has 6 employees.
What is the current trading status of Phio Pharma (PHIO)?
As of May 01, 2026, Phio Pharma (PHIO) is trading at a price of 1.220 USD, with a previous close of 1.220 USD. The stock has fluctuated within a day range of 1.191 USD to 1.230 USD, while its 52-week range spans from 0.813 USD to 4.190 USD.
What Is Phio Pharma (PHIO) Price Target According to Analysts?
The average 12-month price target for Phio Pharma is 14.000 USD, with a high estimate of 14 USD and a low estimate of 14 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,047.54% Upside potential.
What Is the PHIO Premarket Price?
PHIO's last pre-market stock price is 1.195 USD. The pre-market share volume is 6,810.000, and the stock has decreased by 0.015, or 1.270%.
What Is the PHIO After Hours Price?
PHIO's last after hours stock price is 1.210 USD, the stock has decreased by -0.010, or -0.820%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.